Brief: FDA Approves Gerresheimer's SQ Innovation's Lasix Onyu
Oct 13 (Reuters) - GERRESHEIMER AG GXIG.DE: FDA APPROVES SQ INNOVATION'S LASIX ONYU FIRST PRODUCTS EXPECTED TO BE AVAILABLE ALREADY IN 2025 Source text: ID:nEQ3Xn0Wba Further company coverage: GXIG.DE (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Gerresheimer AG
See all newsGermany's Gerresheimer prelim Q3 revenue rises on strong demand for drug delivery devices
Brief: Gerresheimer Reports Q3 Revenue Of EUR 605 Mln
Brief: Gerresheimer Completes Sale Of Centor
Brief: Gerresheimer Targets Leverage At Or Below 3x Net Debt To Ebitda
Gerresheimer gains as Q2 shows quarter-on-quarter recovery